Innovation in the Diagnostics

On Thursday, Dr. Dirk Schneider, the president of the Förderverein swissbiolabs, introduced us to the “Innovations in Diagnostics”. One of his main topics covered the personalized healthcare, which is stimulated by the possibilities arising from the use of diagnostics. By tailoring healthcare to patients’ needs, they are allowing the right treatment to reach the right patients at the right time and move away from a one-size-fits all approach. Personalized healthcare shifts health-systems from being treatment-centered to being comprehensively patient-centered. In this evolution the diagnostic industry plays an important role as it is growing at a rapid pace. Especially the molecular diagnostics has the potential to cut down on overtreatments, reduce waste in the practice of healthcare, and give physicians a new arsenal in their fight to treat patients. Molecular diagnostics is one technology of In Vitro Diagnostics (IVD), which can make an important contribution to make the healthcare systems more efficient. IVDs are tests on bodily samples like blood, tissue or urine and are used to detect diseases, conditions, or infections. IVD companies embrace technological innovations, e.g. remote monitoring through phones. The diagnostic testing play an important role in increasing the knowledge base, as they provide insights into the links between individuals, their illnesses and their treatment. Therefore, the scientific understanding of health and wellbeing is constantly improving. In future, we will not all be taking the same medicine for the same diseases, but we will have the best treatment for every individual patient.

The innovations in diagnostics have a high potential to improve medical services. They can lead to personalized medicines and treatments, what not only for institutions can be an interesting evolution as it reduces various costs but also for patients as they do not have to try multiple treatments with different side effects. As in the other fields, it will be a question for companies to adopt the innovation or stay stuck to traditional ways. Dr. Dirk Schneider provided us with some very interesting insights into the industry of diagnostics. He also added theoretical knowledge about genetics, different cancer types, and how they can be cured or at least be treated.

0 Kommentare

Dein Kommentar

Want to join the discussion?
Feel free to contribute!

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert.

Diese Website verwendet Akismet, um Spam zu reduzieren. Erfahre mehr darüber, wie deine Kommentardaten verarbeitet werden.